Transgenomic announced this week the resignation of the chairman of its board of directors, Collin D’Silva.
D’Silva was a co-founder of Transgenomic and served as president and CEO from 1998 to 2006. D’Silva has also resigned from his position as secretary of the company, though he will remain as director of mergers and acquisitions until March 31.
Transgenomic board member Gregory Sloma will serve as chairman on an interim basis until a new chairman is appointed. In addition, Craig Tuttle, the company’s current president and CEO, has been elected to the board to fill the vacancy created by D'Silva's resignation, and CFO Debra Schneider has been appointed secretary.
Beckman Coulter director Hugh Coble will be retiring from the company’s board on Feb. 2, the firm said in a Securities and Exchange Commission filing last week.
Strategic Diagnostics last week said it has named Stan Fronczkowski to be chief financial officer and Faye Coggins as executive director of marketing.
Fronczkowski spent 29 years with Keystone Foods, and served as vice president of international finance and COO for Keystone Europe, Middle East and Africa, and as vice president of finance for Asia-Pacific.
Coggins most recently was vice president of marketing for the life science research division of Fisher Biosciences. He has also been executive director for Qiagen.
Kim Fechtel is the new senior director of scientific consulting at 3rd Millennium, the company said last week.
In the new position, Fechtel will be responsible for business development and will be a principal investigator and scientific leader for R&D grants.
Fechtel is former senior director of bioinformatics at Genome Therapeutics and was involved in bioinformatics projects at Proteome and at the Genetics Institute.